Navigation Links
Segal McCambridge Singer & Mahoney, Ltd. and Greenberg Traurig, LLP Obtain Three Defense Verdicts for I-Flow in Oregon Infusion Pump Cases
Date:11/9/2010

ATLANTA, Nov. 9, 2010 /PRNewswire/ -- Segal McCambridge Singer & Mahoney, Ltd. and Greenberg Traurig, LLP obtained three defense verdicts at trial in favor of medical device manufacturer I-Flow Corporation.  A federal jury in the United States District Court for the District of Oregon returned defense verdicts on all counts in favor of I-Flow, and against each of three plaintiffs whose cases had been consolidated for trial.  The plaintiffs sought between $11 million and $19 million in total damages for alleged permanent, disabling shoulder injuries known as post-arthroscopic glenohumeral chondrolysis (PAGCL).  All three plaintiffs claimed that they sustained PAGCL after infusion pumps manufactured by I-Flow were used to infuse local anesthetics into their shoulders following arthroscopic surgeries they underwent in 2004.  

After four weeks of evidence and five hours of deliberation, the jury returned three unanimous defense verdicts for I-Flow.  The jury found that plaintiffs failed to prove that the pumps were defective, or that there were inadequate warnings related to the pumps or use of them, or that the pumps caused the plaintiffs' alleged injuries.  The consolidated cases, Christina McClellan v. I-Flow Corporation, et al., Juan Huerta v. I-Flow Inc., et al., and Danny Arvidson v. DJO, LLC, et al., were decided on Friday, October 15, 2010.

The defense trial team was led by Jeffrey Singer and Mark Crane of Segal McCambridge Singer & Mahoney, Ltd. and Lori Cohen and Scott Campbell of Greenberg Traurig, LLP. The cases are the first in the infusion pump litigation to be tried by this defense team.  


'/>"/>
SOURCE Greenberg Traurig, LLP
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimers Disease
2. World-Renowned Singer Youssou NDour Launches NightWatch Program
3. Interleukin Genetics and Geisinger to Collaborate on Genetic Tests to Predict Weight Loss Success
4. Argos Therapeutics to Present Potential of its Arcelis™ Immunotherapy as an Innovative, Effective Treatment for HIV at the APHA 138th Annual Meeting & Exposition
5. Intercell AG Announces Q3 2010 Results and Updates on R&D Progress and Management
6. How IT Helps Solve Pharmas R&D Problems: in silico Drug Discovery
7. Robbins & Myers to Present at Bairds 2010 Industrial Conference November 9, 2010
8. Study Published This Week in Alzheimers & Dementia: The Journal of the Alzheimers Association Shows that Algal DHA Improved Memory and Learning in Healthy Adults Age 55 and Older
9. Applications Now Being Accepted for SBS 17th Annual Conference & Exhibition Academic Travel Awards
10. NeoGenomics Awarded $374,000 in R&D Grants from the US Government
11. Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , Oct. 12, 2017 West ... in innovative solutions for injectable drug administration, today announced ... the market opens on Thursday, October 26, 2017, and ... results and business expectations at 9:00 a.m. Eastern Time. ... or 253-336-8738 (International). The conference ID is 94093362. ...
(Date:10/11/2017)... FRISCO, Texas , Oct. 11, 2017 /PRNewswire/ ... healthcare services, has amplified its effort during National ... patients about hereditary cancer risks. ... Journal of Clinical Oncology calculated that more than ... to have inherited mutations in BRCA1 or BRCA2 and ...
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
Breaking Medicine Technology:
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... Milford, NJ (PRWEB) , ... October 13, 2017 , ... ... weekend at scenic Alexandria Park in Milford, NJ. This free event, sponsored by ... and physical activity. The fun run is geared towards children of all ages; ...
(Date:10/13/2017)... Fairfax, VA (PRWEB) , ... October 13, 2017 ... ... provider of DevOps and Agile Software Development, has been awarded a contract by ... (EATS) Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
Breaking Medicine News(10 mins):